Indicated for: thrombolysis; myocardial infarction; ischemic stroke
Route of administration: injectable / infusion
Substance: streptokinase (thrombolytic)
ATC: B01AD01 (Blood and blood forming organs | Antithrombotic agents | Enzymes)
Streptokinase is a thrombolytic medication used to dissolve blood clots in cases of acute myocardial infarction, pulmonary embolism, or deep vein thrombosis. It works by activating plasminogen, which breaks down fibrin in clots.
The medication is administered intravenously under strict medical supervision, usually in intensive care units. It is important for patients to be monitored to prevent complications such as excessive bleeding.
Patients should be aware of potential side effects, such as allergic reactions, fever, or hypotension. It is important to inform the doctor of any unusual symptoms.
Common side effects include fever, hypotension, and allergic reactions. In rare cases, severe bleeding or anaphylactic reactions may occur. Patients should be informed of these risks before administration.